NASDAQ · IVAL

Alpha Architect International Quantitative Value ETF (IVAL)

$36.35−1.18%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$36.35▲ 19.93% in range
Sep 29, 2025Low $29.29 · High $37.41Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

Alpha Architect International Quantitative Value ETF closed at $36.35 on Sep 28, down 1.18%, 2.8% below its 52-week closing high. Volume of 11.9K shares was 0.69× its 20-day average (below normal).

Split-adjusted performance: -2.2% over one month, +9.7% over six months, +20.3% over one year.

Short interest was 67.1K shares at the Sep 15 settlement, down 32.4% from the prior report (3.3 days to cover).

Market cap$221.7M6.1M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield2.28%$0.2068 last paid
52-week range29.29 – 37.41−2.8% from high
Volume11.9K0.69× 20-day avg
Volatility · 60d11.8%Annualised
Short % of float—3.3 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W −1.4%1M −2.2%3M +6.5%6M +9.7%YTD +15.5%1Y +20.3%3Y +48.1%5Y +33.2%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short67.1K−32.4% vs prior
Days to cover3.3Settled Sep 15
% of float—
Short vol. 10d71.3%of daily volume

News about Alpha Architect International Quantitative Value ETF

All news →

No recent articles focused on Alpha Architect International Quantitative Value ETF.

Quick answers

What is IVAL's market cap?
$221.71M, based on the Sep 28 close of $36.35.
Does Alpha Architect International Quantitative Value ETF pay a dividend?
Yes. The latest regular dividend was $0.2068 per share (ex-date Sep 28), an annualised yield of 2.28%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology